XML 22 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Income and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Research and development expenses $ (5,698) $ (7,274) $ (5,587)
General and administrative expenses (4,204) (4,775) (4,967)
Operating loss (9,902) (12,049) (10,554)
Financing income (expenses), net (308) 1,942 62
Net loss and comprehensive loss $ (10,210) $ (10,107) $ (10,492)
Basic net loss per share (in Dollars per share) $ (0.54) $ (0.74) $ (0.91)
Diluted net loss per share (in Dollars per share) $ (0.54) $ (0.74) $ (0.91)
Weighted average number of ordinary shares used in computing basic net loss per share (in Shares) 18,602,082 13,640,168 11,504,521
Weighted average number of ordinary shares used in computing diluted net loss per share (in Shares) 18,602,082 13,640,168 11,504,521